BELLUS Health Inc
TSX:BLU
Balance Sheet
Balance Sheet Decomposition
BELLUS Health Inc
BELLUS Health Inc
Balance Sheet
BELLUS Health Inc
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
11
|
1
|
1
|
1
|
2
|
1
|
6
|
6
|
150
|
87
|
|
| Cash |
11
|
1
|
1
|
1
|
2
|
1
|
6
|
6
|
32
|
13
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
118
|
74
|
|
| Short-Term Investments |
4
|
10
|
6
|
4
|
17
|
35
|
85
|
93
|
99
|
250
|
|
| Total Receivables |
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
2
|
|
| Accounts Receivables |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Other Current Assets |
1
|
1
|
2
|
1
|
0
|
1
|
3
|
3
|
8
|
17
|
|
| Total Current Assets |
16
|
12
|
10
|
6
|
21
|
37
|
94
|
102
|
258
|
356
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Intangible Assets |
1
|
1
|
0
|
0
|
2
|
2
|
2
|
50
|
50
|
50
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
5
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Assets |
22
N/A
|
14
-35%
|
11
-25%
|
7
-34%
|
23
+220%
|
39
+72%
|
96
+147%
|
153
+59%
|
310
+102%
|
408
+32%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
2
|
1
|
1
|
1
|
0
|
0
|
7
|
6
|
3
|
5
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
11
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
2
|
2
|
2
|
0
|
0
|
1
|
0
|
0
|
3
|
3
|
|
| Total Current Liabilities |
3
|
3
|
3
|
1
|
2
|
2
|
8
|
6
|
17
|
16
|
|
| Long-Term Debt |
5
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Minority Interest |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
4
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
13
N/A
|
7
-45%
|
4
-40%
|
1
-77%
|
2
+80%
|
2
+11%
|
8
+280%
|
6
-21%
|
18
+193%
|
17
-4%
|
|
| Equity | |||||||||||
| Common Stock |
394
|
360
|
303
|
332
|
372
|
369
|
486
|
575
|
799
|
977
|
|
| Retained Earnings |
416
|
382
|
321
|
345
|
371
|
351
|
434
|
469
|
517
|
596
|
|
| Other Equity |
31
|
29
|
25
|
19
|
21
|
20
|
36
|
41
|
9
|
9
|
|
| Total Equity |
9
N/A
|
7
-21%
|
7
-10%
|
6
-5%
|
21
+237%
|
37
+78%
|
89
+139%
|
147
+66%
|
292
+99%
|
391
+34%
|
|
| Total Liabilities & Equity |
22
N/A
|
14
-35%
|
11
-25%
|
7
-34%
|
23
+220%
|
39
+72%
|
96
+147%
|
153
+59%
|
310
+102%
|
408
+32%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
13
|
13
|
13
|
17
|
33
|
44
|
55
|
78
|
106
|
127
|
|